MENU
CADL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Candel Therapeutics (CADL) Ownership - Who owns Candel Therapeutics?
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more
Profile
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
326.63M
P/E Ratio
N/A
Total Cash
100.69M
Projected Growth
N/A
Total Debt
8.34M
Revenue
N/A
Risk (Beta)
-2.39
Dividend Yield
N/A
Total Cash/Share
1.83
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CADL
Capitalization
327M
P/E Ratio
N/A
Risk (Beta)
-2.39
Dividend Yield
N/A
Total Cash
101M
Total Cash/Share
1.83
Total Debt
8.34M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
90.2M
P/B Ratio
3.62
Cash Flow
N/A
Earnings
-0.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
549K
Current Ratio
7.04
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-19.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.42
Shares Held By Institutions
179M
Shares Outstanding - Current
54.9M
Total Liabilities
15.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-31.452
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CADL showed earnings on August 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com